1809743
Last Update Posted: 2013-11-13
Recruiting has ended
All Genders accepted | 18 Years-80 Years |
100 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Regadenoson and Adenosine
The aim of the study is to test the accuracy of Regadenoson to induce maximal and steady state hyperemia as compared to central venous infusion of adenosine for assessing fractional flow reserve. (adenosine is considered to be the gold standard)and to investigate the time intervals of maximum hyperemia induced by centrally and peripherally administered Regadenoson.
Eligibility
Relevant conditions:
Coronary Artery Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov